Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059559) titled 'Observational study for the frequency of nocturnal hypoglycemia with switching SGLT2 inhibitors.' on Nov. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Iwate Medical University
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluating hypoglycemic events using continuous glucose monitoring (CGM) before and after switching SGLT2 inhibitors.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) 20 years or older at the time of the agreement
2) Within two to ten-weeks period after switching SGLT2 inhibitors.
3) Obtaining written consent for the participation in this study
Key exclusion criteria - 1) Changing the diabetic medicine except SGLT2 inhibitor after the hypoglycemia confirmation of the former SGLT2 inhibitor
2) Judging to be inappropriate for study entry from medical grounds by physicians
3) Not obtaining written consent for the participation in this study
Target Size - 30
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 09 Month 02 Day
Anticipated trial start date - 2025 Year 11 Month 01 Day
Last follow-up date - 2027 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068066
Disclaimer: Curated by HT Syndication.
